StocktoriaBullFrog AI Holdings, Inc. BFRG
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $116,670 | — | $65,000 | $10,000 | — |
| Gross profit | $21,892 | — | $59,800 | $9,200 | — |
| Operating income | -$6.6M | -$7.2M | -$5.4M | -$2.5M | -$555,362 |
| Net income | -$6.5M | -$7.0M | -$5.4M | -$2.8M | -$585,840 |
| Operating cash flow | -$5.5M | -$5.6M | -$6.0M | -$910,890 | -$382,405 |
| Free cash flow | — | — | — | -$919,634 | — |
| Total assets | $2.8M | $5.6M | $2.8M | $80,369 | $10,014 |
| Total liabilities | $672,022 | $588,090 | $184,350 | $3.1M | $1.0M |
| Shareholders' equity | $2.1M | $5.0M | $2.6M | -$3.1M | -$1.0M |
| Ratios | |||||
| Gross margin | 18.8% | — | 92.0% | 92.0% | — |
| Operating margin | -5652.4% | — | -8257.7% | -24558.0% | — |
| Net margin | -5569.6% | — | -8239.8% | -28024.9% | — |
| FCF margin | — | — | — | -9196.3% | — |
| Return on assets | -231.4% | -126.0% | -192.9% | -3487.0% | -5850.2% |
| Return on equity | -304.2% | -140.9% | -206.6% | 91.7% | 58.1% |
| Current ratio | 3.85 | 9.43 | 15.03 | 0.02 | 0.01 |
| Revenue growth | — | — | 550.0% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 12,000 | $20,160 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001829247 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.